收藏本站万方检测维普检测中文降重英文语法检测 Turnitin UK版 Turnitin 国际版

登录注册

文献互助

发帖

版主：xxs1234, 1127761702, MRQ, 猜才彩蔡, 1764992075, ARomeo

主题分类：

↓ 下拉展示

新窗全部主题最新热门热帖精华更多

0回复

alandan 3 天前

10 Genomic and Immune Landscape of Non-Small Cell Lung Cancer Brain Metastases.

ASCO
1已完成

嗦了蜜 7 天前

10 Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer WithFGFR2Rearrangement: A Case Report and Review of the Literature

ASCO
1已完成

张志霞 7 天前

50 Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP

ASCO
1已完成

zljhmz 2026-8-24

20 Phase III Evaluation of Treatment Combinations in Three-Arm Trials

ASCO
1已完成

小翘翘 2026-8-21

10 Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application

ASCO
1已完成

bocheng 2026-8-14

10 Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors

ASCO
1已完成

重要的菠萝 2026-8-9

10 Modern Advancements in Radiation Oncology: What Every Oncologist Should Know

ASCO
1已完成

大岩石 2026-8-7

10 Beyond Parametric Assumptions: Unsupervised Methods Enhance DNA Repair Gene Discovery inSMARCAL1Identification

ASCO
1已完成

外向无敌 2026-8-5

10 Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

ASCO
1已完成

895216486 2026-8-5

10 Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma

ASCO
0回复

zyl0531 2026-7-31

10 Breaking the stromal barrier in bladder tumor with a urea-powered platelet nanomotor for potentiated BCG immunotherapy.

ASCO
1已完成

张志霞 2026-7-29

50 Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer

ASCO
0回复

张志霞 2026-7-29

50 Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome

ASCO
1已完成

r1168 2026-7-25

10 US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer

ASCO
0回复

沉默的螺旋 2026-7-24

10 Current Management of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in a Changing Landscape

ASCO
0回复

Jade1989 2026-7-20

10 Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

ASCO
1已完成

lj1234567897897 2026-7-17

20 Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial

ASCO
0回复

嗦了蜜 2026-7-17

20 Clinical significance ofEGFRamplification in patients withEGFR-mutated metastatic non–small cell lung cancer receiving first-line osimertinib.

ASCO
0回复

KakMac 2026-7-16

10 Development and External Validation of a Transcriptome-Based Multivariable Prediction Model for Treatment-Free Remission in Chronic Myeloid Leukemia

ASCO
1已完成

zipple00 2026-7-15

10 US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer

ASCO

12 3 4 5 6 7 8 9 10 ... 18 / 18 页下一页

悬赏问答

最新回复

站点公告

今日热心研友

（热心研友QQ群）

Powered by 谷粉学术社区X3.4 Copyright © 2001-2025.

湘ICP备2021017706号

深度AI学术|深度AI学术搜索|AI科研狗|小黑屋|版权归属及声明|